Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-74.75%
operating margin TTM
-92.66%
revenue TTM
34.08 Million
revenue per share TTM
0.36$
valuation ratios | |
|---|---|
| pe ratio | -20.62 |
| peg ratio | -1.05 |
| price to book ratio | 3.04 |
| price to sales ratio | 16.08 |
| enterprise value multiple | -18.87 |
| price fair value | 3.04 |
profitability ratios | |
|---|---|
| gross profit margin | -13.32% |
| operating profit margin | -92.66% |
| pretax profit margin | -74.75% |
| net profit margin | -74.75% |
| return on assets | -13.36% |
| return on equity | -16.47% |
| return on capital employed | -17.68% |
liquidity ratios | |
|---|---|
| current ratio | 10.45 |
| quick ratio | 10.45 |
| cash ratio | 3.30 |
efficiency ratios | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 24.03 |
| days of payables outstanding | 41.97 |
| cash conversion cycle | -17.94 |
| receivables turnover | 15.19 |
| payables turnover | 8.70 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.02 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -6.38 |
cash flow ratios | |
|---|---|
| free cash flow per share | -2.06 |
| cash per share | 9.00 |
| operating cash flow per share | -2.03 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -6.38 |
| short term coverage ratios | 0.00 |
| capital expenditure coverage ratio | -58.85 |
Frequently Asked Questions
When was the last time IDEAYA Biosciences, Inc. (NASDAQ:IDYA) reported earnings?
IDEAYA Biosciences, Inc. (IDYA) published its most recent earnings results on 04-08-2026.
What is IDEAYA Biosciences, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. IDEAYA Biosciences, Inc. (NASDAQ:IDYA)'s trailing twelve months ROE is -16.47%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. IDEAYA Biosciences, Inc. (IDYA) currently has a ROA of -13.36%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did IDYA's net profit margin stand at?
IDYA reported a profit margin of -74.75% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is IDYA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 10.45 in the most recent quarter. The quick ratio stood at 10.45, with a Debt/Eq ratio of 0.02.